CBT
Cabot Corporation
Specialty Chemicals · Basic Materials · United States
73.85
close · 2026-10-29
value
73
cheaper than peers73
quality
46
stronger fundamentals46
ranked against
Specialty Chemicals
value
quality
42 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 7.88× | 88 |
| forward P/E | 10.53× | 75 |
| price to sales | 1.24× | 60 |
| price to book | 2.38× | 44 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 13.3% | 71 |
| operating margin | 10.0% | 48 |
| debt to equity | 73.4% | 47 |
| revenue growth | 6.4% | 35 |
4 of 4 measures available
Facts
| market cap | $4B |
| free cash flow | $248.1M |
| employees | 4,064 |
| first trade | 1980-11-05 |
| next earnings | 2026-11-02 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 6.02 | 6.72 | 7.73 | 3.62 |
| free cash flow | $391.0M | $451.0M | $351.0M | -$111.0M |
| net income | $331.0M | $380.0M | $445.0M | $209.0M |
| revenue | $3.71B | $3.99B | $3.93B | $4.32B |
| unusual items | $0 | $0 | -$3.0M | -$183.0M |